Close
Almac
Achema middle east

IT & Data Management

Data on over 2,300 Lung Cancer Biomarkers Mapped in New Global Database

A new database has been created to support pharmaceutical and biotech companies in the creation of new drugs to treat lung cancer, bringing the creation of personalised treatment for people fighting the disease one step closer. It has been created...

Pharmaceutical Compound Synthesis Getting The AI Refinement

Researchers from the University of Cambridge, UK, along with a leading global pharmaceutical company, have gone on to develop an AI-powered platform that can very well refine as well as accelerate the way pharmaceuticals have been designed and made. Their...

Digital Backdrop In Pharma & The Change It Is Experiencing

The enlarged significance of digital innovation has prominently transformed how pharma goes on to function. A worldwide surge in traffic when it comes to health and medicine websites has only moved forward. The fact is that larger numbers of...

GenAI & Its Prominence To Speed-Up Pharmaceuticals To Market

The fact is that Generative AI- GenAI is revolutionizing the life sciences sector, and one is just at the surface of it. It is worth noting that, on average, it takes almost seven years to come up with a new...

GenAI & Its Current Scenario In The World of Pharmaceuticals

According to a recent survey from the Pistoia Alliance, AI and machine learning- ML are going to be the top technology investments when it comes to 60% of life sciences companies in the next two years. 1 With this growing...

SaaS & Cloud Communication With AI – A Pharma Future Indeed

The pharmaceutical backdrop is going through a remarkable shift pushed by disruptive technologies: Software as a Service- SaaS, Infrastructure as a Service- IaaS as well as Artificial Intelligence- AI. These technologies are revolutionizing pharma operations across the world. SaaS...

Development and Validation of a Patient Toolkit to Help Overcome the Challenges Faced in the Management of Patients with Cirrhosis with Ascites

Executive Summary Liver disease is currently the second leading cause of years of working life lost in Europe, second only to ischaemic heart disease1. An analysis of the interaction between patients with cirrhosis with ascites (CwA), caregivers, and healthcare providers...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »